Getting new bronchodilator compounds from molecular topology

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Computational Chemistry

Background:

• Bronchodilator drug discovery is crucial for respiratory diseases.
• Traditional methods often require understanding the mechanism of action (MOA).
• Molecular topology offers an alternative screening approach.

Purpose of the Study:

• To identify novel bronchodilator compounds using molecular topology.
• To evaluate the efficacy of selected compounds compared to theophylline.
• To demonstrate the utility of molecular topology in drug discovery.

Main Methods:

• Screening a large chemical database (12,000 compounds) using molecular topology.
• Assessing bronchodilator activity through relaxation and potency assays.
• Comparing novel compounds against theophylline as a reference drug.

Main Results:

• Identified a small percentage (<5%) of compounds with bronchodilator activity.
• Tetrahydro-papaveroline demonstrated superior relaxation (93.9%) and potency (pD2=7.30) compared to theophylline (77.0%, pD2=4.69).
• Some compounds showed concentration-dependent relaxation.

Conclusions:

• Molecular topology is an effective strategy for discovering new bronchodilators.
• This method bypasses the need for explicit MOA knowledge.
• The identified compounds represent promising leads for further development.